| Application | Comment | Organism |
|---|---|---|
| medicine | glycogen phosphorylase inhibitory flavonoids have potential to contribute to the protection or improvement of control of diabetes type II | Rattus norvegicus |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| 6-hydroxyluteolin | - |
Rattus norvegicus | |
| hypolaetin | - |
Rattus norvegicus | |
| isoscullarein | - |
Rattus norvegicus | |
| luteolin | - |
Rattus norvegicus | |
| quercetagetin | noncompetitive | Rattus norvegicus | |
| quercetin | - |
Rattus norvegicus |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Rattus norvegicus | - |
male, Wistar | - |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| glycogen + glucose 1-phosphate | - |
Rattus norvegicus | glycogen + phosphate | - |
? |
| Synonyms | Comment | Organism |
|---|---|---|
| GP b | - |
Rattus norvegicus |
| Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
|---|---|---|---|---|---|
| 0.0035 | - |
quercetagetin | pH 6.8, 25°C | Rattus norvegicus |
| IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
|---|---|---|---|---|---|
| 0.0097 | - |
pH 6.8, 25°C | Rattus norvegicus | quercetagetin | |
| 0.0116 | - |
pH 6.8, 25°C | Rattus norvegicus | 6-hydroxyluteolin | |
| 0.0157 | - |
pH 6.8, 25°C | Rattus norvegicus | hypolaetin | |
| 0.0297 | - |
pH 6.8, 25°C | Rattus norvegicus | luteolin | |
| 0.0335 | - |
pH 6.8, 25°C | Rattus norvegicus | quercetin | |
| 0.0461 | - |
pH 6.8, 25°C | Rattus norvegicus | isoscullarein |